Director James Poole Sells 3,000 Shares of Cal-Maine Foods Inc

Director James Poole has sold 3,000 shares of Cal-Maine Foods Inc (CALM, Financial) on February 14, 2024, according to a recent SEC Filing. Cal-Maine Foods Inc is the largest producer and marketer of shell eggs in the United States. The company's primary business is the production, grading, packaging, marketing, and distribution of shell eggs.

Over the past year, the insider has sold a total of 3,000 shares and has not made any purchases of the company's stock. The recent transaction is part of a trend observed over the past year, where there have been no insider buys and four insider sells for Cal-Maine Foods Inc.

1758349755517399040.png

On the date of the insider's recent sale, shares of Cal-Maine Foods Inc were trading at $55.91, giving the company a market capitalization of $2.796 billion. The stock's price-earnings ratio stands at 6.17, which is below both the industry median of 18.11 and the company's historical median price-earnings ratio.

According to the GF Value, with a share price of $55.91 and a GuruFocus Value of $72.22, Cal-Maine Foods Inc has a price-to-GF-Value ratio of 0.77, indicating that the stock is considered Modestly Undervalued.

1758349772697268224.png

The GF Value is a proprietary intrinsic value estimate from GuruFocus, which is calculated based on historical trading multiples, a GuruFocus adjustment factor related to the company's past performance, and future business performance estimates provided by Morningstar analysts.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.